top of page

KHIDI Hosts U.S. Market Entry Strategy Seminar and Signs MOU with NEBS (11.16.2026)

4 hours ago
1 min read
  • Date: 11.16.2026 (Mon)

  • Location: Santo Domingo (5F) & Bogota (3F), 1 Broadway, Cambridge

  • Korea Health Industry Development Institute (KHIDI) hosted the K-Biohealth U.S. Market Entry Strategy Seminar at Santo Domingo (5F) in the Cambridge Innovation Center (CIC) in Boston, bringing together tenant companies from its Boston and Texas C&D Incubation Offices. The seminar featured expert presentations on global pharmaceutical partnering, FDA regulatory strategies, Chemistry, Manufacturing, and Controls (CMC), and intellectual property (IP). Participating companies also received one-on-one consultations tailored to their business development and U.S. market entry needs.

  • Later that day, KHIDI signed a Memorandum of Understanding (MOU) with the New England Bioscience Society (NEBS) at Bogota (3F) in CIC to strengthen collaboration between Korean biohealth companies and life sciences professionals in the New England region. “Boston is a global biohealth innovation hub with outstanding research infrastructure, skilled professionals, and a strong investor network,” said Younghoon Jung, Executive Director of KHIDI. “Through this MOU, we aim to strengthen connections between Boston-based experts and Korean companies while expanding practical support for their entry into the U.S. market.”

    Source: KHIDI Press Release



Comments


© 2026 KHIDI USA ALL RIGHT RESERVED

bottom of page